Inhibition of glycogen synthase kinase-3β prevents activation of focal adhesion kinase after ischemia/reperfusion of the rat lung

Clinical Hemorheology and Microcirculation

Volumn 46, Issue 2-3, 2010, Pages 169-181

  Waldow, Thomas ^a   Witt, Wolfgang ^a   Matschke, Klaus ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

focal adhesion kinase; Glycogen synthase kinase; ischemia reperfusion; Src; TGF beta1

Indexed keywords

FOCAL ADHESION KINASE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 6; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ISCHEMIA; LEUKOCYTE; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG ISCHEMIA; NONHUMAN; PNEUMONIA; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY;

ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GLYCOGEN SYNTHASE KINASE 3; LUNG; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SRC-FAMILY KINASES; THIADIAZOLES;

EID: 78650450579     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2010-1343     Document Type: Article

References (42)

1. M. Alderliesten, M. de Graauw, J. Oldenampsen, Y. Qin, C. Pont, L. van Buren and B. van de Water, Extracellular signal- regluated kinase activation during renal ischemia/reperfusion mediates focal adhesion dissolution and renal injury, Am J Pathol 171 (2007), 452-462.
2. R. Barillas, I. Friehs, H. Cao-Danh, J.F. Martinez and P.J. del Nido, Inhibition of glycogen synthase kinase-3fi improves tolerance to ischemia in hypertrophied hearts, Ann Thorac Surg 84 (2007), 126-133.
3. S. Bhattacharya, N. Sen, M.T. Yiming, R. Patel, K. Parthasarathi, S. Quadri, A.C. Issekutz and J. Bhattacharya, High tidal volume ventilation induces proinflammatory signaling in rat lung endothelium, Am J Respir Cell Mol Biol 28 (2003), 218-224.
4. L.A. Cohen and J.L. Guan, Mechanisms of focal adhesion kinase regulation, Curr Cancer Drug Targets 5 (2005), 629-643.
5. S. Cuzzocrea, C. Crisafulli, E. Mazzon, E. Esposito, C. Muià, M.Abdelrahman, R. DiPaolaandC. Thiemermann, Inhibition of glycogen synthase kinase-3fi attenuates the development of carregeenan-induced lung injury in mice, Br J Pharmacol 149 (2006), 687-702.
6. S. Cuzzocrea, T. Genovese, E. Mazzon, E. Esposito, C. Muia, M. Abdelrahman, R. Di Paola, P. Bramanti and C. Thiemermann, Glycogen synthase kinase-3fi inhibition attenuates the development of bleomycin-induced lung injury, Int J Immunopathol Pharmacol 20 (2007), 621-632.
7. M. de Perrot, M. Liu, T.K. Waddell and S. Keshavjee, Ischemia- reperfusion-induced lung injury, Am J Respir Crit Care Med 167 (2003), 490-511.
8. L.P Desai, S.E. Sinclair, K.E. Chapman, A. Hassid and CM. Waters, High tidal volume mechanical ventilation with hyperoxia alters alveolar type II cell adhesion, Am J Physiol Lung Cell Mol Physiol 293 (2007), 769-778.
9. I.M. Downey, A.M. Davis and M.V. Cohen, Signaling pathways in ischemic preconditioning, Heart Fail Rev 12 (2007), 181-188.
10. L. Dugo, M. Collin and C. Thiemermann, Glycogen synthase kinase 3 (3 as a target for the therapy of shock and inflammation, Shock 27 (2007), 113-123.
11. T. Gori, G. Di Stolfo, S. Dragoni, M. Lisi, M.C. Leone, S. Forconi and J.D. Parker, The mechanism of nitrate-induced preconditioning, Clin Hemorheol Microcirc 39 (2008), 191-196.
12. E.R. Gross, A.K. Hsu and G.J. Gross, Opioid-induced cardioprotection occurs via glycogen synthase kinase (3 inhibition during reperfusion in intact rat hearts, Circ Res 94 (2004), 960-966.
13. S. Grotti and T. Gori, Endothelium, ischemia and the good side of oxygen free radicals, Clin Hemorheol Microcirc 39 (2008), 197-203.
14. S. Hoepken, R. Fuhrmann, F. Jung and R.P. Franke, Shear resistance of human umbilical endothelial cells on different materials covered with or without extracellular matrix: Controlled in-vitro study, Clin Hemorheol Microcirc 43 (2009), 157-166.
15. R.S. Jope, C.J. Yuskaitis and E. Beurel, Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics, Neurochem Res 32 (2007), 577-595.
16. M. Juhaszova, D.B. Zorov, S.H. Kim, S. Pepe, Q. Fu, K.W. Fishbein, B.D. Ziman, S. Wang, K. Ytrehus, C.L. Antos, E.N. Olsen and S.J. Sollott, Glycogen synthase kinase-3(3 mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore, J Clin Invest 113 (2004), 1535-1549.
17. S. Kaga, L. Zhan, E. Altaf and N. Maulik, Glycogen synthase kinase-3 fi/fi-catenin promotes angiogenic and anti-apoptic signaling through the induction of VEGF, Bcl-2 and surviving expression in rat ischemic preconditioned myocardium, J Moll Cell Cardiol 40 (2006), 138-147.
18. S. Keshavjee, X.M. Zhang, S. Fischer and M. Liu, Ischemia reperfusion-induced dynamic changes of protein tyrosine phosphorylation during human lung transplantation, Transplantation 70 (2000), 525-531.
19. L.Y. Lee, U.S. Kayyali, A.M. Sousa, T. Rajan, R.J. Lechleider and R.M. Day, Transforming growth factor-fi1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src, Am J Respir Cell Mol Biol 37 (2007), 485-493.
20. D. Mehta and A.B. Malik, Signaling mechanisms regulating endothelial permeability, Physiol Rev 86 (2006), 279-367.
21. T. Miyahara, K. Hamanaka, D.S. Weber, D.A. Drake, M. Anghelescu and J.C. Parker, Phosphoinositide 3-kinase, Src, and akt modulate acute ventilation-induced vascular permeability increase in mouse lungs, Am J Physiol Lung Cell Mol Physiol 293 (2007), L11-L21.
22. H.P Monteiro, R.J. Arai and L.R. Travassos, Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling, Antioxid Redox Signal 10 (2008), 843-889.
23. E. Murphy and C. Steenbergen, Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury, Physiol Rev 88 (2008), 581-609.
24. E. Murphy and C. Steenbergen, Preconditioning: The mitochondrial connection, Annu Rev Physiol 69 (2004), 51-67.
25. C.S.H. Ng, S. Wan, A.A. Arifi and A.PC. Yim, Inflammatory response to pulmonary ischemia-reperfusion injury, Surg Today 36 (2006), 205-214.
26. M. Nishihara, T. Miura, T. Miki, J. Sakamoto, M. Tanno, H. Kobayashi, Y. Ikeda, K. Ohori, A. Takahashi and K. Shimamoto, Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphoylation of glycogen synthase kinase-3fi, Am J Physiol Heart Circ Physiol 291 (2006), 748-755.
27. F.N. Obame, C. Plin-Mercier, R. Assaly, R. Zini, J.L. Dubois-Randé, A. Berdeaux and D. Morin, Carioprotective effect of morphine and a blocker of glycogen synthase kinase 3(3 SB216763 [3-(2, 4-Dichlorophenyl)-4(1-methyl-1H-indol-3-yl)- 1H-pyrrole-2, 5-dione], via inhibition of the mitochondrial permeability transition pore, J Pharmacol Exp Ther 326 (2008), 252-258.
28. D. Okutani, M. Lodyga, B. Han and M. Liu, Src protein tyrosine kinase family and acute inflammatory responses, Am J Physiol Lung Cell Mol Physiol 291 (2006), L129-L141.
29. PS. Pagel, J.G. Krolikowski, D.A. Neff, D. Weihrauch, M. Bienengraeber, J.R. Kersten and D.C. Warltier, Inhibition of glycogen synthase kinase enhances isoflurane-induced protection against myocardial infarction during early reperfusion in vivo, Anesth Analg 102 (2006), 1348-1354.
30. S.S. Park, H. Zhao, R.A. Mueller and Z. Xu, Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta, J Moll Cell Cardiol 40 (2006), 708-716.
31. L.H. Romer, K.G. Birukov and J.G.N. Garcia, Focal adhesions: Paradigm for a signaling nexus, Circ Res 98 (2006), 606-616.
32. J.B. Seal and B.L. Gewertz, Vascular dysfunction in ischemia-reperfusion injury, Ann Vasc Surg 19 (2005), 572-584.
33. L. Sínay, M. Kürthy, Sz. Horváth, E. Arotó, M. Shafiei, J. Lantos, S. Ferencz, A. Bátor, B. Balatonyi, Zs. Verzár, B. Sütõ, L. Kollár, Gy. Wéber, E. Rõth and G. Jancsó, Ischemic postconditioning reduces peroxide formation, cytokine expression and leukocyte activation in reperfusion injury after abdominal aortic surgery in rat model, Clin Hemorheol Microcirc 40 (2008), 133-142.
34. H. Tong, K. Imahashi, C. Steenbergen and E. Murphy, Phosphorylation of glycogen synthase kinase 3(3 during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective, Circ Res 90 (2002), 377-379.
35. K. Vadali, X. Cai and M.D. Schaller, Focal adhesion kinase: An essential kinase in the regulation of cardiovascular functions, IUBMB Life 59 (2007), 709-716.
36. T. Waldow, K. Alexiou, W. Witt, F.M. Wagner, V. Gulielmos, K. Matschke and M. Knaut, Attenuation of reperfusion- induced systemic inflammation by preconditioning with nitric oxide in an in situ porcine model of normothermic lung ischemia, Chest 125 (2004), 2253-2259. (Pubitemid 38788197)
37. T. Waldow, W. Witt, A. Buzin, A. Ulmer and K. Matschke, Prevention of ischemia/reperfusion-induced accumulation of matrix metalloproteinases in rat lung by preconditioning with nitric oxide, J Surg Res 152 (2009), 198-208.
38. T. Waldow, W. Witt, A. Janke, A. Ulmer, A. Buzin and K. Matschke, Cell-cell junctions and vascular endothelial growth factor in rat lung as affected by ischemia/reperfusion and preconditioning with inhaled nitric oxide, J Surg Res 157 (2008), 30-42.
39. T. Waldow, W. Witt, A. Ulmer, A. Janke, K. Alexiou and K. Matschke, Preconditioning by inhaled nitric oxide prevents hyperoxic and ischemia/reperfusion injury in rat lungs, Pulm Pharmacol Ther 21 (2008), 418-429.
40. T. Waldow, W. Witt, E. Weber and K. Matschke, Nitirc oxide donor-induced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells, Nitric Oxide 15 (2006), 103-113.
41. M.H. Wu, Endothelial focal adhesions and barrier function, Am J Physiol 569 (2007), 359-366.
42. S. Yang, R. Yip, S. Polena, J. Gricius, K.J. Desai, M. Sharma, C. Ruby, J. Gintautas and H. Jerome, Ischemia induced focal adhesion kinase cleavage in rat lung, Proc West Pharmacol Soc 47 (2004), 57-62.